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Abstract
Background: The human kinome containing 478 eukaryotic protein kinases has over 100 uncharacterized kinases with
unknown substrates and biological functions. The Ser/Thr kinase 35 (STK35, Clik1) is a member of the NKF 4 (New Kinase
Family 4) in the kinome with unknown substrates and biological functions. Various high throughput studies indicate that
STK35 could be involved in various human diseases such as colorectal cancer and malaria.
Methodology/Principal Findings: In this study, we found that the previously published coding sequence of the STK35 gene
is incomplete. The newly identified sequence of the STK35 gene codes for a protein of 534 amino acids with a N-terminal
elongation of 133 amino acids. It has been designated as STK35L (STK35 long). Since it is the first of further homologous
kinases we termed it as STK35L1. The STK35L1 protein (58 kDa on SDS-PAGE), but not STK35 (44 kDa), was found to be
expressed in all human cells studied (endothelial cells, HeLa, and HEK cells) and was down-regulated after silencing with
specific siRNA. EGFP-STK35L1 was localized in the nucleus and the nucleolus. By combining syntenic and gene structure
pattern data and homology searches, two further STK35L1 homologs, STK35L2 (previously known as PDIK1L) and STK35L3,
were found. All these protein kinase homologs were conserved throughout the vertebrates. The STK35L3 gene was
specifically lost during placental mammalian evolution. Using comparative genomics, we have identified orthologous sets of
these three protein kinases genes and their possible ancestor gene in two sea squirt genomes.
Conclusions/Significance: We found the full-length coding sequence of the STK35 gene and termed it as STK35L1. We
identified a new third STK35-like gene, STK35L3, in vertebrates and a possible ancestor gene in sea squirt genome. This study
will provide a comprehensive platform to explore the role of STK35L kinases in cell functions and human diseases.
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Introduction
Protein kinases mediate signal transduction in eukaryotic cells
and are involved in regulating all cellular processes such as
transcription, translation, cell cycle progression, cytoskeleton
rearrangements, migration, apoptosis and differentiation. Eukary-
otic protein kinases that phosphorylate serine/threonine (Ser/Thr)
or tyrosine (Tyr) residues are the largest superfamily of enzymes,
comprising ,1.7% of all human genes [1]. Since completion of
the first draft of the human genome sequence, various groups
estimated the number of human kinases as 448, 510, and 518
depending on methods and data set used in the analysis [1–3].
Based on the current kinase databases (www.kinase.com; http://
hodgkin.mbu.iisc.ernet.in/,king/), and a study by Stevan Hanks,
the estimated number of human eukaryotic kinases (ePKs) is now
478 [4]. Most protein kinases have regulatory domains located C-
terminal and/or N-terminal to the kinase domain. Despite the
differences in their substrate specificities, the kinase domain of
Ser/Thr- and Tyr- kinases is highly conserved and composed of
two lobes with an overall length of roughly 275 amino acids [5].
The catalytic domain is characterized by a series of short sequence
motifs, which define 11 sub domains and serve as key elements in
the catalytic core of the kinase domain [6]. These motifs in
combination with the overall catalytic domain sequence can be
used to identify genes in genomes that encode protein kinases by
various approaches such as sequence alignments and hidden
Markov model searches. Such analysis and corresponding cDNA
sequence information permits prediction of the number of protein
kinases in different genomes [1]. The human kinome has over 100
uncharacterized kinases with unknown substrates and biological
functions.
STK35 and its homolog PDIK1L (PDLIM1 (CLP36) Interact-
ing Kinase 1 Like) shares 69% protein sequence identity in kinase
domain. They are members of the NKF4 (New Kinase Family 4)
Ser/Thr kinases (STK) family and classified in group ‘‘Other’’
in the human kinome [www.kinase.com; 1,7, 8]. In Kinomer
database, the best match for the STK35 kinase sequence is within
the group TKL (Tyrosine Kinase Like) [9].
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STK35 has also been named as Clik1 (CLP36 Interacting
Kinase 1) based on one study that showed an association of
STK35 with CLP36 after overexpression of both proteins in
osteosarcoma cells [7]. CLP36 is an a-actinin binding protein,
which contains a LIM- and a PDZ-domain and is mainly localized
on stress fibers [10]. Therefore, a possible function of STK35 in
the regulation of the actin cytoskeleton was proposed [7].
The biological function and substrates of STK35 are not
known. The STK35 gene was found upregulated specifically in
colorectum cancer [11]. The expression of STK35 gene was
altered in a rodent model of Parkinson disease [12]. A kinome-
wide RNAi screen revealed that STK35 silencing was among top
five hits leading to reduced infection of hepatocytes by Plasmodium
berghei sporozoites [13]. These studies suggest that STK35 may
play a role in various human diseases deserving immediate
attention by scientists working in different fields of biology and
medicine.
In the present study, we describe the correct genomic
organization and coding sequence of STK35, now renamed
STK35L1, which was localized in the nucleus and nucleolus. We
identified a new kinase subfamily containing three STK35L genes
conserved in vertebrates. The present comprehensive study will
provide a platform to further analyze the functional role and
regulation of the STK35L kinases.
Results
EGFP-STK35 co-expressed with CLP36 does not
translocate to stress fibers in endothelial cells
Previously, it has been shown that myc-tagged Clik1 (STK35)
translocated from the nucleus to actin stress fibers upon
coexpression with EGFP-CLP36 in U2OS osteosarcoma cells
[7]. To test whether the translocation of STK35 to actin stress
fibers could be observed in endothelial cells, we transfected
endothelial cells with EGFP-STK35 plasmid alone or together
with mRFP-CLP36 plasmid. In cells transfected with EGFP-
STK35 only, we found the EGFP-STK35 protein predominantly
nuclear with a faint cytoplasmic localization (Figure 1A). Unex-
pectedly, the coexpression of EGFP-STK35 and mRFP-CLP36
did not lead to translocation of STK35 to the cytoplasm and stress
fibers (Figure 1B1 and 1B2) as reported previously. Moreover, we
could not observe the presence of CLP36 in EGFP-STK35
immunoprecipitates from endothelial cells (data not shown). These
data suggest that CLP36 interaction with STK35 does not occur
ubiquitously. Therefore, the former designation of this kinase
STK35 was used.
Expression of STK35 RNA in various cell types
To investigate STK35 mRNA expression in different cell types,
total RNA was isolated from endothelial, HEK and HeLa cells
and analyzed by RT-PCR. A fragment of the expected size for
STK35 (273 bp) was amplified with STK35 specific primers
(Table S1) in all cell types (Figure 2A). The correct sequence for
STK35 fragment was confirmed by DNA-sequencing of the
amplified product. Hence, endothelial, HeLa, and HEK cells
express a transcript for STK35. By quantitative RT-PCR, we
found that STK35 is equally expressed in these cell types (data not
shown). To exclude a false positive amplification of possible DNA
contamination of the isolated RNA, the primers for STK35 were
designed to bind exactly at the exon-intron boundaries. No
additional amplification of a genomic fragment of STK35
including the intron (13.3 kbp) was obtained in addition to the
fragment derived from the STK35 mRNA transcript. In order to
obtain further information about the expression profile of STK35
in human tissues and cell lines, we searched the Unigene database
for Expressed Sequence Tags (ESTs) of STK35. 217 ESTs were
found for the human STK35 gene, which are present in most of
the tissues such as testis, ovary, skin, brain, heart, liver, and eye.
To analyze the relative expression of STK35 RNA in various
human tissues, we obtained the gene expression profile of STK35
from the SymAtlas database (http://symatlas.gnf.org) [14].
STK35 is expressed in all 79 human tissues studied. In testis
and CD56+ NK cells, the expression was higher (Figure S1).
Expression of STK35 in various cell types at protein level
To analyze the expression of endogenous STK35 protein in
cells, rabbit polyclonal peptide antibodies against a C-terminal
STK35 peptide were raised. To test the specificity of the antibody,
cell lysates of untransfected and endothelial cells transiently
transfected with plasmids encoding for EGFP-tagged STK35
proteins were used as negative and positive controls respectively.
The antibody recognized the over-expressed proteins (,72 kDa
for EGFP-STK35) and a prominent band at about 58 kDa
specifically whereas the pre-immune serum of the same rabbit did
not detect these bands (data not shown). Importantly, we could not
observe in transfected and non-transfected cells a band at
44.6 kDa, the theoretical calculated molecular weight of endog-
enous STK35. During the course of the study a commercial
polyclonal goat anti-STK35 peptide antibody against the C-
terminal amino acid sequence (ELETRMDQVTCAA) of STK35
became available. This antibody recognized the EGFP-STK35
fusion proteins which contain the C-terminal part of the protein
specifically (EGFP-STK35, EGFP-STK35D1-63) but not a
Figure 1. EGFP-STK35 (Clik1) does not translocate to actin stress fibers upon mRFP-CLP36 coexpression. Endothelial cells were
transfected with EGFP-STK35 plasmid alone (A) or cotransfected with mRFP-CLP36 (B). The nuclear localization of EGFP-STK35 protein (A, green) was
not affected by coexpression of mRFP-CLP36 (B1). mRFP-CLP36 (Red) was mainly localized on actin stress fibers (B2).
doi:10.1371/journal.pone.0006981.g001
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truncated construct lacking this sequence (EGFP-STK35D72-400)
(Figure 2B). The blot incubated with mouse anti-EGFP antibody
clearly showed a band of this truncated construct confirming its
expression in cells (Figure 2B). Beside the detection of the EGFP-
tagged STK35 proteins, again a band of 58 kDa was specifically
recognized by the goat anti-STK35 antibody but not by the anti-
EGFP antibody (Figure 2B). This indicates that this 58 kDa band
could represent endogenous STK35 protein.
To analyze further, nuclear lysates of endothelial, HEK and
HeLa cells were prepared. A prominent band at 58 kDa was
recognized by the anti-STK35 antibody in nuclear extracts of
HEK, HeLa and endothelial cell (Figure 2C) and macrophages
(data not shown). In HeLa cells two additional bands at about
52 kDa and 48 kDa were detected. The control blot probed with
goat IgG did not show any bands. The theoretical molecular
weight of STK35 (44.6 kDa) is significantly less than the molecular
weight of the endogenous protein (58 kDa) recognized by these
two different antibodies. Posttranslational modification as expla-
nation for such a large mobility shift from 45 kDa to 58 kDa
seemed to us unlikely. Moreover, overexpressed EGFP-tagged
STK35 would be expected to undergo the same posttranslational
modifications as endogenous STK35 in endothelial cells but this
was not the case: the detected molecular weight of this tagged
protein corresponded exactly to its calculated molecular weight.
We also examined the possibilities of longer STK35 gene splice
variants from data set of Ensembl and NCBI human build.
However, no splice variants co-relation can be established.
Therefore, we undertook a careful genome analysis of the
STK35 locus.
Identification of STK35 protein coding region in different
genomes
To identify the open reading frame of the STK35 gene, we
analyzed the genomic sequence of the STK35 locus in different
genomes from different representative species of vertebrate phyla
using various gene structure prediction tools. First we used the
ElDorado tool of Genomatix GmbH (http://www.genomatix.de/).
We used STK35 cDNA (NM_080836) sequence for complete
analysis of the STK35 locus in human genome. The STK35 gene is
located on chromosome 20 subregion p13 (Figure 3A). The
chromosomal region NC_000020 between 2.013.772 and
2.063.771 (50.000 bp) was analyzed. Three transcription start
regions (TSR_2.030.439–484, TSR_2.030.648–690 and
TSR_2.031.306–335) were found based on CAGE (Cap-analysis
gene expression) tags profile. CAGE is a high-throughput method to
measure expression levels of a gene and is an essential resource for
profiling transcriptional starting sites [15,16]. The transcription
start region TSR_2.030.439–484 was 1035 bp upstream of the
previously defined STK35 start codon. This region was highly
conserved among mammals (Figure 3B). We investigated this region
for coding sequences manually and by using different gene
prediction software such as FGENESH (www.softberry.com). We
identified a start codon surrounded by a Kozak consensus sequence
and an open reading frame encoding a protein of 534 amino acids
instead of the 401 amino acids predicted earlier for STK35
(Figure 3C and 3D). The theoretical molecular weight of the
predicted protein was 58 kDa which matched completely the
molecular weight of the endogenous protein on the immunoblots.
Furthermore, we found that the new STK35 gene has 3 coding
exons (Figure 3C). The newly identified STK35 gene structure is
maintained from fish to mammals (Figure 4). In contrast, the
previously identified protein start codon of the STK35 gene is found
in the middle of second exon.
Figure 2. Expression analysis of STK35. (A) To verify the expression
of STK35 mRNA, RNA and cDNA were prepared from endothelial,
HEK293 and HeLa cells. 273 bp PCR products were amplified with STK35
specific primers from cDNA pools of endothelial, HEK and HeLa cells. b-
actin amplification was used as a control. The primer pairs correspond
to different exons to ensure the amplification from mature RNA. (B)
Endothelial cells (EC) were transiently transfected with plasmids
encoding different constructs of EGFP-STK35. Cell lysates of transfected
or untransfected EC were immunoblotted with goat anti-STK35
antibody, or with mouse anti-EGFP as expression control. The detected
bands correspond to the size of the fusion proteins (EGFP-STK35_D72-
400: 35 kDa; EGFP-STK35_D1-6: 66 kDa; EGFP-STK35:72 kDa. The
construct lacking the C-terminal part (EGFP-STK35_D72-400) was not
recognized by anti.STK35 antibody. Note the additional band at 58 kDa
in all lanes blotted with the anti-STK35-antibody (arrow). (C) Nuclei of
EC, HEK and HeLa cells were isolated, and lysates were immunoblotted
with goat anti-STK35 antibody or goat IgG as control. The bands
detected by the antibody could not be found with the goat IgG control.
In EC, HEK and HeLa nuclear lysates and in the whole cell lysate of EGFP-
STK35 transfected cells a band of 58 kDa could be detected. In EGFP-
STK35 (72 kDa) transfected cells, additional band of 72 kDa was
detected. EC were transfected with pooled STK35L1 siRNA or control
siRNA. After 24 to 72 hours of transfection, cell lysates were examined
by western blotting with anti-STK35 antibody. After 72 hours,
expression of 58 kDa band of STK35 protein was reduced by 80%.
Actin blot was performed as control for equal loading.
doi:10.1371/journal.pone.0006981.g002
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Figure 3. Genomic analysis of STK35L1. (A) Schematic representation of the published STK35 (Clik1) gene. The location on chromosome 20 is
shown. The coding region is shown in blue. (B) The structure of the STK35 locus after identification of the putative TSR. The 1035 bp sequence
between TSR and the start codon of the published gene is highly conserved among mammals as shown in % identity. (C) Schematic representation of
the STK35L1gene. The 59 extended sequence is marked in light blue. (D) The putative start codon of the STK35L1 gene matches the Kozak consensus
sequence RccAUGG. Some nucleotides in this sequence are more important than others. For a ‘strong’ consensus, the nucleotides at positions +3 (G)
and 23 (R =A or G) must both match the consensus. [42]. E) mRNA expression of the STK35L1 gene. Upper panel: Amplification of the expressed
transcripts of STK35L1 from human EC cDNA. The lower axis: the putative mRNA transcript of STK35L1 gene and its length in base pairs. The extended
sequence to the 59 end is shown in light blue, the previously published sequence is represented in dark blue. Positions of introns are indicated as
white bars. Arrows over the axis represent the relative position of primers used for the amplification of cDNA. The sizes of the three obtained PCR
products are indicated.
doi:10.1371/journal.pone.0006981.g003
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Figure 4. Alignment of protein sequence of STK35L1 from different vertebrates human (HSAP), mouse (MMUS) rat (RNOR), and
zebrafish (DRER). Red arrow indicates the newly identified start codon while blue arrow head indicates start codon previously published. The
position of kinase domain is indicated by blue line. The STK35L1 kinase domain of zebrafish has 81% identity with human kinase domain.
doi:10.1371/journal.pone.0006981.g004
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To investigate the presence of mRNA transcripts of the
potentially longer form of STK35 experimentally, endothelial cell
total RNA was isolated and analyzed by RT-PCR. The primers
were designed to span the introns boundaries and to combine the
extended predicted sequence with the published sequence of
STK35 (Figure 3E). The RT-PCR results show an expression of
mRNA transcripts of the newly identified STK35 gene including
exon 1 (Figure 3E). The correct sequences of these PCR-amplified
products were confirmed by DNA-sequencing (data not shown).
Possible genomic DNA contamination was excluded by using
negative control (reverse transcriptase polymerase was excluded
during RT-PCR) of RT-PCR samples (Figure S3). This data
indicates that the longer form of STK35 is expressed in mammals.
Hence, based on our finding we termed the full length gene of
STK35 as STK35L (STK35 Long). Since it represents the first
member of NKF4 family, it is named STK35L1.
Knockdown of endogenous STK35L1 expression by
siRNA
In order to prove that the endogenous 58 kDa protein band is
STK35L1, we used the siRNA approach to knockdown the
expression of endogenous STK35L1. We designed siRNA directed
against three different regions of STK35L1 gene (Table S1).
Indeed, the expression of 58 kDa band was highly reduced in
endothelial cells (by ,80%) after transfecting a pool of the three
siRNA oligonucleotides (Figure 5). One siRNA oligonucleotide
(siSTK35L_1111) could downregulate 70% of the 58 kDa protein,
whereas the others (siSTK35L_839 and siNSTK35L_5816) were
less effective (data not shown). These data confirm that the
endogenous 58 kDa protein is STK35L1.
Subcellular distribution of STK35L1
To analyze the subcellular distribution of STK35L1, EGFP-
STK35L1 plasmids were transfected into endothelial cells and
analyzed by fluorescent microscopy. The protein accumulated
primarily in the nucleus. Moreover, EGFP-STK35L1 was
concentrated in dense bodies in the nucleus (Figure 6, white
arrow), that were easily identified as nucleoli by phase contrast
microscopy and exclusion of Hoechst DNA staining dye (Figure 6).
The construct deleted of the first 196 N-terminal amino acids
(EGFP-Kinase), containing only the kinase domain, diffusely
distributed throughout the cytoplasm and the nucleus (Figure 6).
These data suggest that the N-terminus of STK35L has a
functional nuclear and nucleolar localization signal.
Identification of STK35L1 orthologous set and gene
conservation in vertebrates
Gene synteny is a useful tool for predicting functional
interaction and relatedness among genes within cluster. Selective
processes are essential to preserve the organization of these clusters
in closely related species. In the human genome, the STK35L1
gene is localized on chromosome 20. On further inspecting this
gene in different vertebrates genome (Table S2), we found that this
gene is maintained in fish, Xenopus and in all mammals. To ensure
orthology of this gene, syntenies amongst different vertebrates
were created. From human to fish, the STK35L1 gene is flanked by
the marker gene PYDN (prodynorphin) in an inverse manner
(Figure 7). Moreover, the STK35L1-PYDN region has tandem
duplication resulting in two copies of these genes in the Danio
genome. These data infer that flanking marker genes are
conserved in micro-syntenic environment corresponding to
STK35L1 synteny. STK35L1 orthologs and species-specific para-
logs are listed in Table S3. Interestingly, the PDYN- STK35L1
locus is not found in Gallus genome using PDYN as marker, since
PDYN was not detectable in the same genomic locus. However, we
could identify the STK35L1 locus by using some other conserved
markers (data not shown). By homology search in Gallus genome,
we found that the STK35L1 gene was truncated and the exon 1
and 2 were missing. The expression of the truncated STK35L1
gene in Gallus is supported by an mRNA sequence submitted in
the gene bank (BU403355).
Identification of STK35L2 orthologous set in vertebrates
STK35L2 (previously known as PDIK1L) is localized on
chromosome 1 in human. In mammals, STK35L2 was conserved
differently: the locus is flanked by a marker tetrad EXTL1-TRIM63-
PHARAH2-STMN1 (Table S4 for markers details) on one side and
the marker gene LIN28 on the other side (Figure 8). However, in
frog and chicken genomes, this gene was only flanked by tetrad
EXTL1-TRIM63-PHARAH2-STMN1 on one side. In fish, the
marker sets were not totally conserved: on one side, the CITED4
gene was present, on the other side, two additional flanking genes–
MANEAL and SF3A3 (Table S4) were present in inverse orientation
to the conserved LIN28. STMN1 gene is maintained from human to
G. asculeatus within an 800 kb fragment. Jointly, LIN28 and STMN1
aided in deciding orthology of STK35L2 gene locus. Hence, this
suggests that STK35L2 has an independent origin from STK35L1.
The human orthologs of STK35L1and STK35L2 were maintained
from fish to humans. STK35L2 orthologs and species-specific
paralogs are listed in Table S3.
Identification of the novel homolog STK35L3 in
vertebrates and characterizing its orthologous set in
different vertebrates
During investigation of STK35L1 and STK35L2 genes from
different vertebrates, we found that some vertebrates possess a
novel STK35L like gene. This gene is not reported in the literature
by today. Since two homologs of the STK35L1 gene are already
known, we named this gene as STK35L3. Astonishingly, this gene
is maintained from fish to mammals as listed in Table 1 with
accession ids and genomic location.
To unravel the origin of STK35L3 gene, the micro-genomic
organization flanking the STK35L3 gene was analyzed (Figure 9).
Figure 5. Knockdown of STK35L1 protein expression. To
knockdown the STK35L1 protein expression, EC were transfected with
pooled STK35L1 siRNA or control siRNA. After 24 to 72 hours of
transfection, cell lysates were examined by western blotting with anti-
STK35 antibody. After 72 hours, expression of 58 kDa band of STK35
protein was reduced by 80%. Actin blot was performed as control for
equal loading.
doi:10.1371/journal.pone.0006981.g005
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In M. domestica (opossum) genome, STK35L3 is gene flanked by
PNOC and ELP3 (Table S4 for markers details) in a ,380 kb
region on chromosome 1. A similar locus is conserved in a
,120 kb fragment on scaffold_470 in frog genome. However in
fish genomes, this locus contains two additional conserved markers
ANKRD5 and EMILIN1 (Table S4) flanking in inverse orientation.
Conservation of locus of STK35L3 suggest that the STK35L3 gene
is found in orthologous condition from fish to mammals, and that
the STK35L3 does not result by tandem duplication of STK35L
genes as they are found in distinct syntenic organization. On
further investigating this gene in different mammals, we found that
this gene is lost in eutherian (‘‘placental’’) mammals (such as
human and mouse in Figure 9), whereas it is retained in
metatherian (‘‘marsupial’’) mammals (as in opossum).This suggests
that STK35L3 gene in eutherians is lost after metatherian\euther-
ian divergence ,173–190 MY ago [17,18,19]. Hence, we
corroborate the finding of novel STK35L3 ortholog in marsupial
mammals, chicken, frog and at least in five fish genomes.
Evolution of STK35L1 and its homologs
Our data clearly demonstrated that there are distinct ortholo-
gous sets of STK35L1 and its homologs in different vertebrate
species. Since these are maintained from fish to human, this
indicates that an ancestor gene might be present before the
emergence of vertebrates or that these genes arose at the point of
vertebrate origin. To identify an ancestor gene of STK35L1,
homology searches in different invertebrate genomes were carried
out. By searching invertebrate model genomes (Table S2) such as
Branchiostoma floridea (lancelets) [20], Strongylocentrotus purpuratus (sea
urchins) [21], Drosophila melanogaster (flies) [22], and Caenorhabditis
elegans (worms) [23], no genuine homologs were found, although
these species possess many eukaryotic protein kinases. However,
we identified a STK35L1 like gene in two genomes of sea squirts -
Ciona intestinalis (JGI Ciona genome accession id -fge-
nesh3_pg.C_chr_07q001099/Ensembl - ENSCINP00000006268)
and Ciona savignyi (Ensembl–ENSCSAV00000013846) with iden-
tity of ,45% with human STK35L1 (Figure S2). Moreover, in a
previous study on the sea urchin kinome [24], STK35 kinase gene
(SPU_003710) had been reported. However by careful compar-
ison of the protein sequence of sea urchin kinase with the
STK35L1 protein, we found that the sea urchin kinase shared only
10% identity with STK35L1 in the kinase domain. To confirm
whether the sea urchin kinase is clustered together with STK35L1
homologs or not in the evolutionary tree, we created a
phylogenetic tree of randomly selected representative kinases with
STK35 homologs, sea urchin and Ciona STK35L1 like kinases
(Figure 10) by using neighboring joining method [25,26]. The
status of the sea urchin kinase being STK35 is highly questionable
as it did not cluster along with STK35L1 homologs in this
phylogenetic tree with a statically significant value (the bootstrap
value is below 60%). This sea urchin kinase randomly located as
other representative kinases in this tree. In contrast the STK35 like
gene in Ciona species is grouped with STK35L1 homologs with a
bootstrap value of 100%. These data suggest that Ciona kinase but
not sea urchin kinase is the closest homlog of the vertebrate
STK35L1.
To compare the evolution of STK35L1, STK35L2, STK35L3 on
a time scale, a time-wise gene distribution of these STK35L1
homologs was created (Figure 11). This finding indicates that
STK35L1 homologs were present from 550 MY ago with
separation of sea squirt lineage from vertebrate lineage. Notably,
the STK33 is the closest homolog of the STK35L1gene (28%
identity of the kinase domain) in comparison to other kinases. An
ancestor gene of STK33 is found in sea anemone genome [27]
from the beginning of metazoan dating ,700 MY ago.
Gene structures of STK35L1 homologs
Gene structures attribute phylogenetic evidence to genes and
aid in assigning origin of given genes. To compare gene structures,
exon-introns architectures of different STK35L1 homologs were
determined. STK35L1 homologs have variable exon-intron
organization patterns (Figure 12). STK35L1 and STK35L2 genes
Figure 6. Subcellular distribution of STK35L1 and its mutants in endothelial cells. Cells transfected with EGFP-STK35L1 or deletion
mutants were fixed and DNA was stained with Hoechst dye. EGFP-NSTK35L1 is mainly localized in nucleus and nucleolus (left panel white arrow). The
nucleolus is excluded by Hoechst-dye staining (middle panel white arrow). In contrast, EGFP-STK35 is mainly localized in nucleus. EGFP-Kinase (N-
terminal 1–196 amino acids of STK35L1 were deleted) is diffusely distributed in the nucleus and the cytoplasm indicating that N-terminal part of
STK35L1 has functional nucleolar localization signal.
doi:10.1371/journal.pone.0006981.g006
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in different vertebrates possess gene structures with ‘three exons/
two introns’ (Figure 12A) and ‘two exons/one intron’ (Figure 12B)
patterns, respectively. STK35L3 from marsupials, chicken and frog
possess a ‘three exons/two introns’ (Figure 12C) pattern. However
STK35L3 from fish carries a discernable ‘four exons/three introns’
gene structure pattern, indicating intron loss from fish to human.
A nine exons/eight introns gene structure pattern is found in
ancestor gene of STK35L1 from Ciona (Figure 12D), suggesting that
the vertebrate STK35L1 gene arose by intron losses event at the
point of vertebrate emergence. The analysis of exon-intron
structures has proved to be a valuable method for determining
phylogenic relatedness of STK35L1 homologs as it suggests
independent origin of these orthologous sets of STK35L1
homologs. Otherwise, a conservation of the intron–exon organi-
zation among these three types of genes would have been
maintained. Additionally, the gene structure patterns of STK35L1
homologs do not resemble that of the closest homologs of serine
threonine kinases (such as STK33/STK38/STK40). This corrobo-
rates that STK35L1 homologs do not share orthology with other
serine threonine kinases.
Discussion
In the present study we found that the previously published
coding sequence of the STK35 gene (code for 401 amino acids) is
incomplete. The newly identified sequence of STK35 gene codes
for a protein of 534 amino acids which was termed as STK35L1.
By western blot analysis of endothelial cell lysates using two
different specific polyclonal anti-STK35 antibodies, we found that
STK35L1 was expressed in all mammalian cells studied. By using
the siRNA approach, we could confirm that the 58 kDa protein is
endogenously expressed STK35L1 protein. In contrast, no
evidence for the expression of STK35 was obtained by western
blotting using the antibodies directed against the C-terminal
peptide of STK35.
Endogenous STK35L1 was found to be localized in the nucleus.
Moreover, EGFP-STK35L1 was also localized in the nucleolus
suggesting a role in gene regulation. A previous report suggested
that STK35 may have role in actin cytoskeleton rearrangement as
the interaction of the co-transfected STK35 and CLP36 proteins
led to relocalization of Clik1 from the nucleus to actin stress fibers
Figure 7. Genomic localizations of STK35L1 and flanking genes in different vertebrates.
doi:10.1371/journal.pone.0006981.g007
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[3]. In endothelial cells, this result could not be confirmed. Recent
studies suggest that STK35 could play a role in various diseases
[11,12,13].
The identification of the full protein coding gene sequence is
obviously crucial for the determination of the biological function of
the kinase. Therefore, we analyzed the STK35 locus in human
genome by using various approaches. Based on CAGE tags, we
found three transcription start regions within a conserved region of
1035 bp upstream of the previously defined STK35 start codon.
CAGE is a high-throughput method to measure expression levels
Figure 8. Genomic localizations of STK35L2 and flanking genes in different vertebrates.
doi:10.1371/journal.pone.0006981.g008
Table 1. Orthologous set of STK35L3 from different vertebrates.
Organism Species Accession id# Genomic location
Opossum Monodelphis domestica (Mdom) ENSMODG00000008648 Chromosome 1: 589,412,721-589,435,590
Chicken Gallus gallus (Ggal) AJ720485.1* Chromosome 3: 108,470,800-108,479,700
Frog Xenopus tropicalis (Xtra) ENSXETG00000021156 Scaffold_470: 254,754-259,637
Zebrafish Danio rerio (Drer) ENSDARG00000042000 Chromosome 20: 32,550,616-32,559,734
Pufferfish Takifugu rubripes (Trub) ENSTRUG00000002570 Scaffold_143: 136,478-140,245
Green spotted pufferfish Tetraodon nigroviridis (Tnig) ENSTNIG00000019170 Chromosome 14: 1,220,644-1,222,657
Stickleback Gasterosteus aculeatus (Gacu) ENSGACG00000004453 GroupXVIII: 1,071,040-1,077,095
Medaka Oryzias latipes (Olat) ENSORLG00000016204 Chromosome 24: 13,431,187-13,437,480
#–Ensemble accession id.
*–NCBI accession id.
doi:10.1371/journal.pone.0006981.t001
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by counting large amounts of sequenced capped 59 ends of
transcripts, termed CAGE tags [15,16]. CAGE tags are an
essential resource for profiling transcriptional starting sites and can
be used for profiling gene expressions by counting CAGE tags
associated with genes. By analyzing the transcription start region
TSR_2.030.439–484 we found a start codon AUG surrounded by
a Kozak sequence upstream 990 bp of the previously published
start codon. The translation initiation sites in eukaryotic mRNAs
are reached via a scanning mechanism which predicts that
translation should start at the AUG codon nearest the 59 end of the
mRNA [28]. So translation initiation from the previously known
start codon which is present in the middle of the second exon is
most unlikely. Indeed, this novel open reading frame coded for a
protein of 58 kDa, exactly the size of the protein band recognized
by the antibody on immunoblot. Moreover, RT-PCR analysis
confirmed the presence of the 58 kDa transcript of STK35L1 in
endothelial cells. Three orthologous sets of STK35L1 homologs
were identified based on syntenic and gene structure pattern data.
STK35L1 is conserved in vertebrates. An exception was chicken
that had a truncated mRNA starting at the third exon translating
only for a partial kinase domain. The present version of the Gallus
genomic sequence is unable to solve this issue; it can be only
clarified with further improvement of genomic assembly of
chicken.
Figure 9. Genomic localizations of STK35L3 and flanking genes in different vertebrates.
doi:10.1371/journal.pone.0006981.g009
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STK35L2 gene is present in all vertebrates in conserved micro-
environment without any exceptions. One of the most exciting
outcomes of the present analysis is the identification of a third
member in this family as STK35L3. Its orthologs are found from
fish to marsupial mammal. However, this gene is lost in placental
mammals after divergence of marsupial and placental mammals at
,173–190 MY ago. Placental mammals have a conserved
syntenic organization, but no STK35L3 gene. It gives a hint that
this gene was lost due to positive selection and might be involved
in physiology related to laying eggs or egg development.
The three sets of STK35L1 homologs have independent gene
structure patterns, further supporting their orthologous status. Any
other known ser/thr kinase family member does not share these
patterns of exon-intron organization. An ancestor of the STK35L1
is identified in two Ciona species that are the closest living relatives
of vertebrates [29]. Additionally, in our analysis we do not find any
evidence to support the presence of STK35 in sea urchin.
Furthermore, no genuine homologs of STK35L1 in worms, flies,
echinoderms and lancelets were found even though these groups of
invertebrate models possess easily identifiable ser/thr kinases.
Thus, it is most likely that the STK35L1 homologs evolved before
the divergence of the vertebrate lineage/Ciona lineage about 550
MY ago.
Furthermore, this comprehensive study will provide a platform
to further analyze the functional role and regulation of the
STK35L1 kinase, and gene transcription in various physiological
and patho-physiological conditions.
Materials and Methods
Materials
Oligonucleotides and siRNAs were synthesized from MWG
Biotech AG (Ebersberg, Germany). Rabbit polyclonal anti-STK35
antibody was generated against the C-terminal peptide 507–521
(DMLANNPQDRPDAF) were generated by Biotrend Chemika-
lien GmbH (Ko¨ln, Germany). Polyclonal goat STK35 antibody
was from Everest Biotech (Oxfortshire, UK). Anti-EGFP antibody
was kindly gifted by Prof. Schleicher (Institute of Cell Biology,
University of Munich, Germany).
RT–PCR
Total RNA was isolated from Endothelial HeLa and HEK cells,
using RNeasy mini kit (Qiagen, Hilden, Germany). First-strand
cDNAs were synthesized with Omniscript reverse transcriptase kit
(Qiagen, Hilden, Germany) using random hexamer primers as per
manufacturer’s protocol. cDNAs from these cell types were
subjected for gene expression analysis using primers. These
primers were designed from different regions of the STK35L1
gene (Table S1).
Construction of the expression plasmids
The full-length coding sequence of STK35 and ST35L1 was
amplified by PCR from a cDNA pool of human umbilical vein
endothelial cell total RNA. The PCR-amplified product of STK35
was cloned into XhoI and HindIII sites of pEGFP-C1 vector
(Clontech) to obtain STK35 fused with EGFP. The full length of
STK35L1 gene was obtained using a multistep cloning strategy. In
the first step PCR, we amplified 39 end of STK35L1 (bp 400–1605)
using primers Clik1_long400F and STK35R_HINDIII (Table S1).
In second step, the 59 end (520 bp) of STK35L1 gene was amplified
using 1_F and 520_R. In third step, the PCR fragments from first
step and second step were mixed in 1:3 molar ratios respectively
and used as PCR template for amplification of the full length
STK35L1gene using 1_F and STK35R_HINDIII primers. The
deletion mutants of EGFP-STK35 were generated by Quik-
Change II site-directed mutagenesis kit (Stratagene, La Jolla, CA)
as per the manufacturer’s instruction. CLP36 gene was amplified
as describe previously [5] and cloned into EcoR1 and Sal1 sites of
pDsRed-Monomer-N1 (Clontech). All the constructs were con-
firmed by DNA sequencing (MWG Biotech AG, Ebersberg,
Germany).
Cell culture and transfection
Human umbilical vein endothelial cells were obtained and
cultured as described previously [30]. Briefly, cells harvested from
umbilical cords were plated onto collagen-coated (room temper-
ature, 75 mg/ml collagen G; Biochrom, Berlin, Germany) plastic
culture flasks and were cultured at 5% CO2, and 37uC in complete
endothelial growth medium (Promo Cell, Heidelberg, Germany).
In all experiments, human umbilical vein endothelial cells up to
third passage were used. HeLa and HEK cells were grown in
OptiMEM medium (Invitrogen) supplemented with 10% fetal calf
serum.
Endothelial cells were transfected using the nucleofaction
transfection technology developed by Amaxa GmbH as per
manufacturer’s instructions.
Figure 10. Evolutionary relationships of STK35L1 and its
homologs with selected kinases. The previously published [24]
probable STK35 gene of Sea urchin is not STK35 gene as do not cluster
with STK35 like genes from other genomes with 60% bootstrap values.
In contrast, Ciona STK35 gene is clustered with STK35 like genes. The
evolutionary history of selected kinases was inferred using the
Neighbor-Joining method [26]. The bootstrap consensus tree inferred
from 1000 replicates is taken to represent the evolutionary history of
these selected kinases [25]. Branches corresponding to partitions
reproduced in less than 60% bootstrap replicates are collapsed. The
percentage of replicate trees in which the associated kinases clustered
together in the bootstrap test (1,000 replicates) are shown above the
branches. The evolutionary distances were computed using the Poisson
correction method and are in the units of the number of amino acid
substitutions per site. All positions containing gaps and missing data
were eliminated from the dataset (Complete deletion option). There
were a total of 227 positions in the final dataset. Phylogenetic analyses
were conducted in MEGA4. Outgroup is yeast STE11 gene choose from
www.kinase.com. SCER–yeast, HSAP–human, DRER- zebrafish, MDOM–
opossum, CINT–sea squirt, SPUR–sea urchin.
doi:10.1371/journal.pone.0006981.g010
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Confocal microscopy
After 8–10 h of transfection, cells were washed fixed with 3.7%
formaldehyde in PBS for 10 minutes at 4uC. For staining of the
DNA, cells were incubated with Hoechst 33258 dye solution
(1 mg/ml) in PBS for 10 minutes. Cells were observed with a Zeiss
LSM510 confocal laser-scanning microscope. The microscope
function was controlled by a light manager through the software
LSM 510 META.
Western blot analysis
Transfected or untransfected endothelial cells or nuclear lysates
(prepared by using nuclei isolation kit from sigma as per
manufacturer’s protocol) of HEK, HeLa and endothelial cells
were dissolved in an equal volume of 26 Laemmli buffer. Equal
amounts of proteins in the samples were subjected to SDS-PAGE
and then transferred to nitrocellulose membrane at 200 mAmp for
60 min at 4uC using the Mini Trans-Blot electrophoresis cell (Bio-
Rad). Membranes were blocked with 5% (w/v) nonfat milk and
incubated with the respective primary and secondary antibodies.
The dilutions of the primary antibodies were: anti-STK35 (1:250)
and anti-EGFP (1:250). The dilution of the secondary antibody
(horseradish peroxidase-conjugated) was 1:5000. The membranes
were developed with SuperSignal West Pico chemiluminescent
substrate (Pierce) and exposed to Hyperfilm (Amersham Biosci-
ences).
Data sources of genomic, cDNA, and protein sequences
The genomic DNA/cDNA/protein sequences from different
organisms were extracted via different types of BLAST [31]
searches using human STK35L1/PDIK1L as query sequence from
the different genomic databases (Table S2). The newly identified
cDNA sequences of STK35L1 and STK35L3 are deposited in
Genbank. GenBank accession numbers of STK35L1 and STK35L3
nucleotide sequences are GQ281297 and GQ281298 respectively.
Ensembl accession identifiers of STK35L1, STK35L2 and STK35L3
genes in different organisms are mention in Table S3.
Gene structure prediction and mapping introns positions
ElDorado tool from Genomatix GmbH (http://www.genomatix.
de/) was used for initial analysis of STK35 gene in human genome.
To ensure correct gene structures of all putative novel kinases, gene
structures were predicted using GENSCAN [32,33] and predictions
were repeated using GENOMESCAN [32,33], GENEWISE [34]
and FGENESH/FGENESH+ (www.softberry.com). Intron-exon
structures were determined with aid of GENEWISE [34] and/or
PROT_MAP (www.softberry.com).
Micro-synteny analysis across different genomes
To verify the orthology, microsynteny across different genomes
were analyzed using NCBI mapviewer, ENSEMBL genome browser
[35], JGI genome browser (http://www.jgi.doe.gov/), Tetraodon
Figure 11. Evolution of STK35L1 homologs in different metazoan genomes. These genes most probably originated from a STK35L1 homolog
from sea squirt. This finding dates the origin of STK35L1 homologs to 550 MY ago. The STK33 gene (28% identity with STK35L1 in the kinase domain) is
found already in the sea anemone genome (accession id e_gw.81.82.1), dating ,700 MY ago. The estimated divergence times (in MY) were taken
from [19] and are marked with red arrows. +, presence, -, absence, *, ancestor gene. ?, information not available.
doi:10.1371/journal.pone.0006981.g011
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genome browser at the Genoscope (http://www.genoscope.cns.fr/
externe/tetranew/) and UCSC genome browser [36,37].
Sequence alignment of protein kinases
Protein alignments of protein kinases were generated with
CLUSTALX 1.83 [38,39]. The alignments were edited and
visualized different sequence characteristics using GENEDOC
[40].
Sequence similarities comparisons between two species
Pairwise protein alignments for STK35L1 and its exons in two
species were carried out by Emboss tool ‘needle’at EBI (http://
www.ebi.ac.uk/Tools/emboss/align/index.html).
Phylogenetic tree analysis
All phylogeny trees were created with full length sequences of
representative serine threonine kinases from different organisms
with help of Neighbor Join (NJ) method [26] using ‘‘MEGA 4’’, a
molecular evolutionary genetics analysis software [41].
Supporting Information
Figure S1 Messenger RNA expression of STK35 in various
human tissues and cells. The expression profile of STK35 in 79
human tissues is shown here. The expression data was obtained
from http://symatlas.gnf.org.
Found at: doi:10.1371/journal.pone.0006981.s001 (0.05 MB TIF)
Figure S2 Multiple protein sequence alignment of human
STK35L1 homologs from human (Hsap), opossum (Mdom) and
its homolog from Ciona (Cint). Human STK35L1 kinase domain
has 45.2% identity and 63.7% similarity with Ciona homolog. The
position of kinase domain (based on human kinase)is indicated by
blue line.
Found at: doi:10.1371/journal.pone.0006981.s002 (0.54 MB TIF)
Figure S3 Expression analysis of STK35. Expression analysis of
STK35. To verify the expression of STK35 mRNA, RNA and
cDNA were prepared from endothelial cells. 455 bp and 755 bp
PCR products (Lane 2 and 3) were amplified with STK35 specific
primers from cDNA pools. No PCR product was amplified in
negative control (reverse transcriptase polymerase was excluded
during RT-PCR).
Found at: doi:10.1371/journal.pone.0006981.s003 (0.11 MB TIF)
Table S1 List of the primers and their sequences.
Found at: doi:10.1371/journal.pone.0006981.s004 (0.04 MB
DOC)
Table S2 List of the genomes of selected species investigated in
the present study.
Found at: doi:10.1371/journal.pone.0006981.s005 (0.04 MB
DOC)
Table S3 Ensembl accession identifiers of STK35L1, STK35L2
(PDIK1L), and STK35L3 genes in different organisms. * NCBI
accession id. # Species specific paralogs.
Figure 12. Variable exon-intron organization of STK35L1 homologs and their ancestor gene from Ciona. Exons are depicted by boxes
and introns by broken lines and labeled with their indicated sizes (bp). An extension of 603 bp of STK35 gene comprising of full exon 1 and part of
exon 2 codes the N-terminal extension of the protein (marked in grey color). Kinase domains are indicated by black line.
doi:10.1371/journal.pone.0006981.g012
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Found at: doi:10.1371/journal.pone.0006981.s006 (0.12 MB
DOC)
Table S4 List of the Markers flanking different STK35L1,
PDIK1L, and STK35L3.
Found at: doi:10.1371/journal.pone.0006981.s007 (0.04 MB
DOC)
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